|Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure|
A Antinori, M Zaccarelli, A Cingolani, F Forbici, MG Rizzo, MP Trotta, ...
AIDS research and human retroviruses 18 (12), 835-838, 2002
|Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients|
M Zaccarelli, V Tozzi, P Lorenzini, MP Trotta, F Forbici, ...
Aids 19 (10), 1081-1089, 2005
|Efficacy of cerebrospinal fluid (CSF)–penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma|
A Antinori, CF Perno, ML Giancola, F Forbici, G Ippolito, RM Hoetelmans, ...
Clinical infectious diseases 41 (12), 1787-1793, 2005
|Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy|
CF Perno, A Cozzi-Lepri, C Balotta, F Forbici, M Violin, A Bertoli, G Facchi, ...
The Journal of infectious diseases 184 (8), 983-991, 2001
|Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors|
V Svicher, T Sing, MM Santoro, F Forbici, F Rodríguez-Barrios, A Bertoli, ...
Journal of virology 80 (14), 7186-7198, 2006
|Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure|
F Ceccherini-Silberstein, F Erba, F Gago, A Bertoli, F Forbici, ...
Aids 18 (12), 11-19, 2004
|Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences|
C Balotta, G Facchi, M Violin, S Van Dooren, A Cozzi-Lepri, F Forbici, ...
Journal of Acquired Immune Deficiency Syndromes 27 (5), 499-505, 2001
|Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to …|
F Ceccherini-Silberstein, V Svicher, T Sing, A Artese, MM Santoro, ...
Journal of virology 81 (20), 11507-11519, 2007
|Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome|
V Tozzi, M Zaccarelli, S Bonfigli, P Lorenzini, G Liuzzi, MP Trotta, F Forbici, ...
Antiviral therapy 11 (5), 553, 2006
|Primary macrophages infected by human immunodeficiency virus trigger CD95‐mediated apoptosis of uninfected astrocytes|
S Aquaro, S Panti, MC Caroleo, E Balestra, A Cenci, F Forbici, G Ippolito, ...
Journal of leukocyte biology 68 (3), 429-435, 2000
|Virologic correlates of adherence to antiretroviral medications and therapeutic failure.|
CF Perno, F Ceccherini-Silberstein, AL De, A Cozzi-Lepri, C Gori, ...
Journal of acquired immune deficiency syndromes (1999) 31, S118-22, 2002
|Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels|
MM Santoro, L Fabeni, D Armenia, C Alteri, D Di Pinto, F Forbici, A Bertoli, ...
Clinical infectious diseases 58 (8), 1156-1164, 2014
|Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens|
V Svicher, C Alteri, A Artese, F Forbici, MM Santoro, D Schols, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (3), 336-344, 2010
|Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor antiretroviral regimens failed|
CF Perno, A Cozzi-Lepri, F Forbici, A Bertoli, M Violin, MS Mura, G Cadeo, ...
The Journal of infectious diseases 189 (11), 1983-1987, 2004
|Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay|
A Casabianca, C Gori, C Orlandi, F Forbici, CF Perno, M Magnani
Molecular and cellular probes 21 (5-6), 368-378, 2007
|Subtype analysis and mutations to antiviral drugs in HIV‐1‐infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme|
MC Bellocchi, F Forbici, L Palombi, C Gori, E Coelho, V Svicher, ...
Journal of medical virology 76 (4), 452-458, 2005
|Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz …|
V Tozzi, M Zaccarelli, P Narciso, MP Trotta, F Ceccherini-Silberstein, ...
The Journal of infectious diseases 189 (9), 1688-1695, 2004
|Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy|
M Zaccarelli, CF Perno, F Forbici, F Soldani, S Bonfigli, C Gori, MP Trotta, ...
Clinical infectious diseases 38 (3), 433-437, 2004
|Macrophages: a crucial reservoir for human immunodeficiency virus in the body.|
E Balestra, CF Perno, S Aquaro, S Panti, A Bertoli, M Piacentini, F Forbici, ...
Journal of biological regulators and homeostatic agents 15 (3), 272-276, 2001
|Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels (< 1,000 copies …|
A Amendola, P Marsella, M Bloisi, F Forbici, C Angeletti, MR Capobianchi
Journal of clinical microbiology 52 (6), 2019-2026, 2014